• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌的细胞计量预后参数。

Cytometric prognostic parameters in breast cancer.

作者信息

Aubele M, Auer G

机构信息

GSF-Forschungszentrum, Institut für Pathologie Oberschleissheim, Germany.

出版信息

Anticancer Res. 1996 Sep-Oct;16(5B):3085-7.

PMID:8920772
Abstract

Prognostic parameters were examined in a retrospective survey of 730 cases of overt distant metastasis-free invasive breast cancer. A multivariate combination of cytometric and clinical parameters allowed the stratification of patients into five prognostic categories. In the low-risk group the distant recurrence rate was only 3.3%, In the highest risk group 57%. We conclude that cytometric parameters can increase the precision of prognostic evaluation in invasive breast cancers, and thus aid in decisions.

摘要

在一项对730例无远处转移的浸润性乳腺癌患者的回顾性调查中,对预后参数进行了研究。细胞计量学参数和临床参数的多变量组合可将患者分为五个预后类别。在低风险组中,远处复发率仅为3.3%,而在最高风险组中为57%。我们得出结论,细胞计量学参数可以提高浸润性乳腺癌预后评估的准确性,从而有助于做出决策。

相似文献

1
Cytometric prognostic parameters in breast cancer.乳腺癌的细胞计量预后参数。
Anticancer Res. 1996 Sep-Oct;16(5B):3085-7.
2
Identification of a low-risk group of stage I breast cancer patients by cytometrically assessed DNA and nuclear texture parameters.通过细胞计量学评估的DNA和核纹理参数识别I期乳腺癌患者的低风险组。
J Pathol. 1995 Dec;177(4):377-84. doi: 10.1002/path.1711770408.
3
Genetic analysis of 53 lymph node-negative breast carcinomas by CGH and relation to clinical, pathological, morphometric, and DNA cytometric prognostic factors.采用比较基因组杂交技术对53例淋巴结阴性乳腺癌进行基因分析,并与临床、病理、形态计量学及DNA细胞计量学预后因素进行相关性研究。
J Pathol. 1998 Dec;186(4):356-62. doi: 10.1002/(SICI)1096-9896(199812)186:4<356::AID-PATH196>3.0.CO;2-Z.
4
Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers.
Oncol Rep. 2002 Jul-Aug;9(4):793-9.
5
S-phase fraction and menopausal status as the most important prognostic factors of disease-free survival for node negative patients with breast cancer. A prospective study.S期分数和绝经状态是乳腺癌淋巴结阴性患者无病生存最重要的预后因素。一项前瞻性研究。
Pol J Pathol. 2003;54(2):101-10.
6
[Prognostic molecular classification of breast cancers based on gene expression profiling].基于基因表达谱的乳腺癌预后分子分类
Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):900-6.
7
In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.在淋巴结阴性的浸润性乳腺癌中,特定的染色体畸变与高有丝分裂活性密切相关,并且比分级、肿瘤直径和雌激素受体更能准确预测预后。
J Pathol. 2003 Dec;201(4):555-61. doi: 10.1002/path.1475.
8
LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.LEA-135表达:其与淋巴结阳性原发性浸润性乳腺癌患者较低的复发风险及总生存期延长的相关性。
Anticancer Res. 2004 Jul-Aug;24(4):2391-400.
9
Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.乳腺肿瘤胞质溶胶中的聚腺苷酸聚合酶酶活性:原发性乳腺癌一种新的独立预后标志物。
Cancer Res. 2000 Oct 1;60(19):5427-33.
10
Prediction of lymph node status by analysis of prognostic factors and possible indications for elective axillary dissection in T1 breast cancers.通过分析预后因素预测T1期乳腺癌腋窝淋巴结状态及选择性腋窝清扫的可能指征
Eur J Surg. 2001 Apr;167(4):255-9. doi: 10.1080/110241501300091381.